ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0083

Confirmatory Factor Analysis of the Plutchik Suicide Risk Scale in Patients with Rheumatoid Arthritis

Pedro Quevedo1, Javier mora2, william garcia2, alejandra Solano2, juliana Muñoz2 and Daniela Lopez2, 1San Rafael Cinic University Hospital, Bogota, Distrito Capital de Bogota, Colombia, 2san rafael clinic universtity hospital, Bogota, Distrito Capital de Bogota, Colombia

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, depression, prevention, quality of life, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0067–0097) Rheumatoid Arthritis – Etiology and Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Prevalence of depression in RA patients ranging from 10% to 25%, making it the most common psychiatric disorder in this population. The Plutchik Suicide Risk Scale is a tool validated in Colombia for assessing suicide risk. It consists of 15 items and evaluates aspects such as suicidal ideation, history of previous attempts, and emotional severity, with a cutoff score of 6 or higher indicating risk. Our Objectives were: To perform an exploratory factor analysis of the Plutchik Suicide Risk Scale in patients with rheumatoid arthritis, and to evaluate the correlation between this score and disease activity and quality of life scales. Additionally, to estimate the prevalence of suicide risk in our population with rheumatoid arthritis.

Methods: A cross-sectional study with ambispective data collection was conducted. Patients over 18 years of age with a diagnosis of rheumatoid arthritis, based on the 2010 ACR/EULAR criteria, and treated at the Rheumatology Department of the Hospital Universitario Clínica San Rafael in Bogotá were included. Patients with major depressive disorder, anxiety disorders, or neurocognitive disorders were excluded. To assess the correlation between the Plutchik scale and the DAS28, HAQ, and CDAI indices, Spearman’s correlation coefficient. For the confirmatory factor analysis (CFA), the weighted least squares means and variance adjusted (WLSMV) estimator was applied, as it is suitable for dichotomous items. A theoretical three-factor model was established, and factor loadings, standard errors, and p-values were calculated. Goodness-of-fit measures were then estimated: chi², TLI (Tucker-Lewis Index), CFI (Comparative Fit Index), SRMR (Standardized Root Mean Square Residual), and RMSEA (Root Mean Square Error of Approximation). The analysis was performed using MPLUS version 8.11 and RStudio version 4.3.2

Results: A total of 91 patients were included in the study, of whom 78% were women. The mean age was 54 years (±14), and the median disease duration was 60 months (120). The median DAS28 score was 3.5 (2.7), and CDAI score was 12 (14). Quality of life, assessed using the HAQ, showed a median score of 1.1 (IQR: 1.55). The Plutchik Suicide Risk Scale yielded a median score of 3 (4.5). When evaluating suicide risk using the Plutchik scale, 26.3% of our population was found to be at risk. Analysis of the correlation between this scale and disease activity scores showed no statistically significant associations with DAS28 or CDAI However, a significant correlation was observed between suicide risk and quality of life, as assessed by the HAQ (rho = 0.60; p < 0.001). The exploratory factor analysis supported a three-factor model, with statistically significant factor loadings for all items except for item P10: "Are you separated, divorced, or widowed?" which had an estimate of 0.19 and a p-value of 0.18. The goodness-of-fit indices indicated acceptable model fit: RMSEA = 0.07, CFI = 0.92, and TLI = 0.91.

Conclusion: The prevalence of suicide risk, according to the Plutchik scale, in our population was 26.3%. A statistically significant correlation was found between this scale and quality of life, demonstrating an acceptable performance of the Plutchik scale in patients with rheumatoid arthritis.

Supporting image 1


Disclosures: P. Quevedo: None; J. mora: None; w. garcia: None; a. Solano: None; j. Muñoz: None; D. Lopez: None.

To cite this abstract in AMA style:

Quevedo P, mora J, garcia w, Solano a, Muñoz j, Lopez D. Confirmatory Factor Analysis of the Plutchik Suicide Risk Scale in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/confirmatory-factor-analysis-of-the-plutchik-suicide-risk-scale-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/confirmatory-factor-analysis-of-the-plutchik-suicide-risk-scale-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology